The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Testing targeted demethylation to overcome resistance to epidermal growth factor receptor (EGFR) blocking agents in wild-type (wt) KRAS metastatic colorectal cancer patients (mCRC).
Ignacio Garrido-Laguna
No relevant relationships to disclose
Kimberly McGregor
No relevant relationships to disclose
Mark Wade
No relevant relationships to disclose
John R. Weis
No relevant relationships to disclose
Laura Burr
No relevant relationships to disclose
Raffaella Soldi
No relevant relationships to disclose
Cynthia Davidson
No relevant relationships to disclose
Loni Jakubowski
No relevant relationships to disclose
Glen Morrell
No relevant relationships to disclose
Jeffrey Olpin
No relevant relationships to disclose
David Jones
No relevant relationships to disclose
Sunil Sharma
No relevant relationships to disclose